{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:18:19Z","timestamp":1793157499704,"version":"4.5.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["FPU18\/06009"],"award-info":[{"award-number":["FPU18\/06009"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["PREP2022-000741"],"award-info":[{"award-number":["PREP2022-000741"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["FPU23\/02246"],"award-info":[{"award-number":["FPU23\/02246"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["PID2022-1381850B-I00"],"award-info":[{"award-number":["PID2022-1381850B-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stichting tegen Kanker and Wereld Kanker Onderzoek Fonds (WKOF), as part of the World Cancer Research Fund International grant programme","award":["IIG_FULL_2023_001"],"award-info":[{"award-number":["IIG_FULL_2023_001"]}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"crossref","award":["BIO-0139"],"award-info":[{"award-number":["BIO-0139"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012514","name":"CIBERobn","doi-asserted-by":"crossref","award":["CIBER is an initiative of Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain"],"award-info":[{"award-number":["CIBER is an initiative of Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain"]}],"id":[{"id":"10.13039\/501100012514","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02925-w","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:27:33Z","timestamp":1778754453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2"],"prefix":"10.1186","volume":"24","author":[{"given":"Jes\u00fas M.","family":"P\u00e9rez-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Prats-Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Gil-Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Arroyo-Mill\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Huertas-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"N\u00fa\u00f1ez-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"L\u00f3pez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Mata-Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gonz\u00e1lez-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Ortea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Porcel-Pastrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"\u00c1lvarez-Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Planque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Carrasco-Valiente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"G\u00f3mez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Guzm\u00e1n-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C.","family":"Fuentes-Fayos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Maria","family":"Fendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel D.","family":"Gahete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Sarmento-Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Mar","family":"Malag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal M.","family":"Luque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"3","key":"2925_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA: Cancer J Clin"},{"issue":"2","key":"2925_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, Fainberg J, Mungovan SF, Bratt O, et al. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023;84(2):191\u2013206. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021.","journal-title":"Eur Urol"},{"issue":"3","key":"2925_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.23736\/s0031-0808.21.04507-9","volume":"64","author":"G Motterle","year":"2022","unstructured":"Motterle G, Zecchini G, Mandato FG, Ferraioli G, Bianco M, et al. Metabolic syndrome and risk of prostate cancer: a systematic review and meta-analysis. Panminerva Med. 2022;64(3):337\u201343. https:\/\/doi.org\/10.23736\/s0031-0808.21.04507-9.","journal-title":"Panminerva Med"},{"issue":"8","key":"2925_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579\u201391. https:\/\/doi.org\/10.1038\/nrc1408.","journal-title":"Nat Rev Cancer"},{"key":"2925_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/978-3-319-48382-5_25","volume-title":"Advances in experimental medicine and biology","author":"A Engin","year":"2017","unstructured":"Engin A. Obesity-associated breast cancer: analysis of risk factors. In: Advances in experimental medicine and biology, vol. 960. 2017. p. 571\u2013606. https:\/\/doi.org\/10.1007\/978-3-319-48382-5_25."},{"issue":"16","key":"2925_CR6","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/jnci\/djg009","volume":"95","author":"E Giovannucci","year":"2003","unstructured":"Giovannucci E, Rimm EB, Liu Y, Leitzmann M, Wu K, Stampfer MJ, et al. Body mass index and risk of prostate cancer in U.S. health professionals. J Natl Cancer Inst. 2003;95(16):1240\u20134. https:\/\/doi.org\/10.1093\/jnci\/djg009.","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2925_CR7","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10552-020-01291-3","volume":"31","author":"S Harrison","year":"2020","unstructured":"Harrison S, Tilling K, Turner EL, Martin RM, Lennon R, Lane JA, et al. Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen. Cancer Causes Control. 2020;31(5):431\u201349. https:\/\/doi.org\/10.1007\/s10552-020-01291-3.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"2925_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/advances\/nmab153","volume":"13","author":"SA Purcell","year":"2022","unstructured":"Purcell SA, Oliveira CLP, Mackenzie M, Robson P, Lewis JD, Prado CM. Body composition and prostate cancer risk: a systematic review of observational studies. Adv Nutr (Bethesda, Md). 2022;13(4):1118\u201330. https:\/\/doi.org\/10.1093\/advances\/nmab153.","journal-title":"Adv Nutr (Bethesda, Md)"},{"issue":"35","key":"2925_CR9","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1200\/jco.2016.67.4283","volume":"34","author":"NM Iyengar","year":"2016","unstructured":"Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol. 2016;34(35):4270\u20136. https:\/\/doi.org\/10.1200\/jco.2016.67.4283.","journal-title":"J Clin Oncol"},{"key":"2925_CR10","doi-asserted-by":"publisher","first-page":"103543","DOI":"10.1016\/j.critrevonc.2021.103543","volume":"169","author":"RL Wilson","year":"2022","unstructured":"Wilson RL, Taaffe DR, Newton RU, Hart NH, Lyons-Wall P, Galv\u00e3o DA. Obesity and prostate cancer: a narrative review. Crit Rev Oncol Hematol. 2022;169:103543. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103543.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"2925_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","volume":"15","author":"DF Quail","year":"2019","unstructured":"Quail DF, Dannenberg AJ. The obese adipose tissue microenvironment in cancer development and progression. Nat Rev Endocrinol. 2019;15(3):139\u201354. https:\/\/doi.org\/10.1038\/s41574-018-0126-x.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2925_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cmet.2017.12.002","volume":"27","author":"RK Zwick","year":"2018","unstructured":"Zwick RK, Guerrero-Juarez CF, Horsley V, Plikus MV. Anatomical, physiological, and functional diversity of adipose tissue. Cell Metab. 2018;27(1):68\u201383. https:\/\/doi.org\/10.1016\/j.cmet.2017.12.002.","journal-title":"Cell Metab"},{"issue":"1","key":"2925_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1620\/tjem.212.55","volume":"212","author":"S Ishidoya","year":"2007","unstructured":"Ishidoya S, Endoh M, Nakagawa H, Saito S, Arai Y. Novel anatomical findings of the prostatic gland and the surrounding capsular structures in the normal prostate. Tohoku J Exp Med. 2007;212(1):55\u201362. https:\/\/doi.org\/10.1620\/tjem.212.55.","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"2925_CR14","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.juro.2009.06.015","volume":"182","author":"DS Finley","year":"2009","unstructured":"Finley DS, Calvert VS, Inokuchi J, Lau A, Narula N, Petricoin EF, et al. Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. J Urol. 2009;182(4):1621\u20137. https:\/\/doi.org\/10.1016\/j.juro.2009.06.015.","journal-title":"J Urol"},{"issue":"1","key":"2925_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1756-9966-31-32","volume":"31","author":"R Ribeiro","year":"2012","unstructured":"Ribeiro R, Monteiro C, Cunha V, Oliveira MJ, Freitas M, Fraga A, et al. Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro. J Exp Clin Cancer Res. 2012;31(1):32. https:\/\/doi.org\/10.1186\/1756-9966-31-32.","journal-title":"J Exp Clin Cancer Res"},{"key":"2925_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/itt.s73223","volume":"5","author":"P Mancuso","year":"2016","unstructured":"Mancuso P. The role of adipokines in chronic inflammation. Immunotargets Ther. 2016;5:47\u201356. https:\/\/doi.org\/10.2147\/itt.s73223.","journal-title":"Immunotargets Ther"},{"issue":"3","key":"2925_CR17","first-page":"737","volume":"28","author":"J Baillargeon","year":"2006","unstructured":"Baillargeon J, Rose DP. Obesity, adipokines, and prostate cancer (review). Int J Oncol. 2006;28(3):737\u201345.","journal-title":"Int J Oncol"},{"issue":"10","key":"2925_CR18","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1210\/en.2017-00370","volume":"158","author":"A Sarmento-Cabral","year":"2017","unstructured":"Sarmento-Cabral A, L-Lopez F, Luque RM. Adipokines and their receptors are widely expressed and distinctly regulated by the metabolic environment in the prostate of male mice: direct role under normal and tumoral conditions. Endocrinology. 2017;158(10):3540\u201352. https:\/\/doi.org\/10.1210\/en.2017-00370.","journal-title":"Endocrinology"},{"key":"2925_CR19","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1038\/ncomms10230","volume":"7","author":"V Laurent","year":"2016","unstructured":"Laurent V, Gu\u00e9rard A, Mazerolles C, Le Gonidec S, Toulet A, Nieto L, et al. Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nat Commun. 2016;7:10230. https:\/\/doi.org\/10.1038\/ncomms10230.","journal-title":"Nat Commun"},{"key":"2925_CR20","doi-asserted-by":"publisher","unstructured":"Cancel M, Pouillot W, Mah\u00e9o K, Fontaine A, Crott\u00e8s D, Fromont G. Interplay between prostate cancer and adipose microenvironment: a complex and flexible scenario. Intern J Mol Sci 2022;23(18). https:\/\/doi.org\/10.3390\/ijms231810762.","DOI":"10.3390\/ijms231810762"},{"key":"2925_CR21","doi-asserted-by":"publisher","first-page":"102547","DOI":"10.1016\/j.ebiom.2019.11.008","volume":"51","author":"JM Jim\u00e9nez-Vacas","year":"2020","unstructured":"Jim\u00e9nez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, G\u00f3mez-G\u00f3mez E, Fuentes-Fayos AC, Le\u00f3n-Gonz\u00e1lez AJ, et al. Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine. 2020;51:102547. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.008.","journal-title":"EBioMedicine"},{"issue":"11","key":"2925_CR22","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1096\/fj.201601264RRR","volume":"31","author":"D Hormaechea-Agulla","year":"2017","unstructured":"Hormaechea-Agulla D, Jim\u00e9nez-Vacas JM, G\u00f3mez-G\u00f3mez E, L-Lopez F, Carrasco-Valiente J, Valero-Rosa J, et al. The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer. FASEB J Off Publ Fed Am Soc Exp Biol. 2017;31(11):4682\u201396. https:\/\/doi.org\/10.1096\/fj.201601264RRR.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"1","key":"2925_CR23","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-017-0713-9","volume":"16","author":"D Hormaechea-Agulla","year":"2017","unstructured":"Hormaechea-Agulla D, Gahete MD, Jim\u00e9nez-Vacas JM, G\u00f3mez-G\u00f3mez E, Ib\u00e1\u00f1ez-Costa A, L-Lopez F, et al. The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness. Mol Cancer. 2017;16(1):146. https:\/\/doi.org\/10.1186\/s12943-017-0713-9.","journal-title":"Mol Cancer"},{"issue":"40","key":"2925_CR24","doi-asserted-by":"publisher","first-page":"eado8231","DOI":"10.1126\/sciadv.ado8231","volume":"10","author":"AJ Montero-Hidalgo","year":"2024","unstructured":"Montero-Hidalgo AJ, Jim\u00e9nez-Vacas JM, G\u00f3mez-G\u00f3mez E, Porcel-Pastrana F, S\u00e1ez-Mart\u00ednez P, P\u00e9rez-G\u00f3mez JM, et al. SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer. Sci Adv. 2024;10(40):eado8231. https:\/\/doi.org\/10.1126\/sciadv.ado8231.","journal-title":"Sci Adv"},{"key":"2925_CR25","doi-asserted-by":"publisher","first-page":"216604","DOI":"10.1016\/j.canlet.2023.216604","volume":"584","author":"P S\u00e1ez-Mart\u00ednez","year":"2024","unstructured":"S\u00e1ez-Mart\u00ednez P, Porcel-Pastrana F, Montero-Hidalgo AJ, de la Lozano HS, Sanchez-Sanchez R, Gonz\u00e1lez-Serrano T, et al. Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1. Cancer lett. 2024;584:216604. https:\/\/doi.org\/10.1016\/j.canlet.2023.216604.","journal-title":"Cancer lett"},{"key":"2925_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.trsl.2022.08.016","volume":"253","author":"JM Jim\u00e9nez-Vacas","year":"2023","unstructured":"Jim\u00e9nez-Vacas JM, Montero-Hidalgo AJ, G\u00f3mez-G\u00f3mez E, S\u00e1ez-Mart\u00ednez P, Fuentes-Fayos AC, Closa A, et al. Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes. Transl Res. 2023;253:68\u201379. https:\/\/doi.org\/10.1016\/j.trsl.2022.08.016.","journal-title":"Transl Res"},{"issue":"1","key":"2925_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21873\/cgp.20110","volume":"16","author":"PA Sacca","year":"2019","unstructured":"Sacca PA, Mazza ON, Scorticati C, Vitagliano G, Casas G, Calvo JC. Human periprostatic adipose tissue: secretome from patients with prostate cancer or benign prostate hyperplasia. Cancer Genom Prot. 2019;16(1):29\u201358. https:\/\/doi.org\/10.21873\/cgp.20110.","journal-title":"Cancer Genom Prot"},{"key":"2925_CR28","doi-asserted-by":"publisher","unstructured":"Romejko K, Markowska M, Niemczyk S. The review of current knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). Int J Mol Sci 2023;24(13) https:\/\/doi.org\/10.3390\/ijms241310470","DOI":"10.3390\/ijms241310470"},{"key":"2925_CR29","doi-asserted-by":"publisher","unstructured":"M\u00fcller N, Scheld M, Voelz C, Gasterich N, Zhao W, Behrens V, et al. Lipocalin-2 deficiency diminishes canonical NLRP3 inflammasome formation and IL-1\u03b2 production in the subacute phase of spinal cord injury. Int J Mol Sci 2023;24(10) https:\/\/doi.org\/10.3390\/ijms24108689","DOI":"10.3390\/ijms24108689"},{"issue":"7","key":"2925_CR30","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/jor.22331","volume":"31","author":"R G\u00f3mez","year":"2013","unstructured":"G\u00f3mez R, Scotece M, Conde J, Lopez V, Pino J, Lago F, et al. Nitric oxide boosts TLR-4 mediated lipocalin 2 expression in chondrocytes. J Orthop Res. 2013;31(7):1046\u201352. https:\/\/doi.org\/10.1002\/jor.22331.","journal-title":"J Orthop Res"},{"key":"2925_CR31","doi-asserted-by":"publisher","unstructured":"Ahn H, Lee G, Kim J, Park J, Kang SG, Yoon SI, et al. NLRP3 triggers attenuate Lipocalin-2 expression independent with inflammasome activation. Cells. 2021;10(7). https:\/\/doi.org\/10.3390\/cells10071660","DOI":"10.3390\/cells10071660"},{"issue":"1","key":"2925_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12974-023-02819-5","volume":"20","author":"J Li","year":"2023","unstructured":"Li J, Xu P, Hong Y, Xie Y, Peng M, Sun R, et al. Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia\/reperfusion injury. J Neuroinflammation. 2023;20(1):148. https:\/\/doi.org\/10.1186\/s12974-023-02819-5.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"2925_CR33","doi-asserted-by":"publisher","first-page":"e4917","DOI":"10.1210\/clinem\/dgab586","volume":"106","author":"V Herrero-Aguayo","year":"2021","unstructured":"Herrero-Aguayo V, S\u00e1ez-Mart\u00ednez P, L\u00f3pez-C\u00e1novas JL, Prados-Carmona JJ, Alc\u00e1ntara-Laguna MD, L\u00f3pez FL, et al. Dysregulation of components of the inflammasome machinery after bariatric surgery: novel targets for a chronic disease. J Clin Endocrinol Metab. 2021;106(12):e4917\u201334. https:\/\/doi.org\/10.1210\/clinem\/dgab586.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2925_CR34","doi-asserted-by":"publisher","first-page":"113700","DOI":"10.1016\/j.celrep.2024.113700","volume":"43","author":"M Pereira","year":"2024","unstructured":"Pereira M, Liang J, Edwards-Hicks J, Meadows AM, Hinz C, Liggi S, et al. Arachidonic acid inhibition of the NLRP3 inflammasome is a mechanism to explain the anti-inflammatory effects of fasting. Cell Rep. 2024;43(2):113700. https:\/\/doi.org\/10.1016\/j.celrep.2024.113700.","journal-title":"Cell Rep"},{"key":"2925_CR35","doi-asserted-by":"publisher","unstructured":"Sztolsztener K, Chabowski A, Harasim-Symbor E, Bielawiec P, Konstantynowicz-Nowicka K. Arachidonic acid as an early indicator of inflammation during non-alcoholic fatty liver disease development. Biomolecules. 2020;10(8). https:\/\/doi.org\/10.3390\/biom10081133","DOI":"10.3390\/biom10081133"},{"issue":"1","key":"2925_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbcan.2012.03.008","volume":"1826","author":"S Chakraborty","year":"2012","unstructured":"Chakraborty S, Kaur S, Guha S, Batra SK. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim Biophys Acta. 2012;1826(1):129\u201369. https:\/\/doi.org\/10.1016\/j.bbcan.2012.03.008.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"2925_CR37","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.ejca.2007.05.013","volume":"43","author":"FJ Kubben","year":"2007","unstructured":"Kubben FJ, Sier CF, Hawinkels LJ, Tschesche H, van Duijn W, Zuidwijk K, et al. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer (Oxford, England\u202f: 1990). 2007;43(12):1869\u201376. https:\/\/doi.org\/10.1016\/j.ejca.2007.05.013.","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"issue":"6","key":"2925_CR38","doi-asserted-by":"publisher","first-page":"115828","DOI":"10.1016\/j.celrep.2025.115828","volume":"44","author":"J Zhang","year":"2025","unstructured":"Zhang J, Rivera KD, Bossi D, Gianfanti F, Nicastri S, Gomes D, et al. An integrated proteomic portrait of prostate cancer progression. Cell Rep. 2025;44(6):115828. https:\/\/doi.org\/10.1016\/j.celrep.2025.115828.","journal-title":"Cell Rep"},{"issue":"1","key":"2925_CR39","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1038\/s41467-021-26840-5","volume":"12","author":"M Bolis","year":"2021","unstructured":"Bolis M, Bossi D, Vallerga A, Ceserani V, Cavalli M, Impellizzieri D, et al. Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression. Nat Commun. 2021;12(1):7033. https:\/\/doi.org\/10.1038\/s41467-021-26840-5.","journal-title":"Nat Commun"},{"issue":"22","key":"2925_CR40","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1158\/1078-0432.ccr-19-1587","volume":"25","author":"DE Spratt","year":"2019","unstructured":"Spratt DE, Alshalalfa M, Fishbane N, Weiner AB, Mehra R, Mahal BA, et al. Transcriptomic heterogeneity of androgen receptor activity defines a de novo low AR-active subclass in treatment na\u00efve primary prostate cancer. Clin Cancer Res. 2019;25(22):6721\u201330. https:\/\/doi.org\/10.1158\/1078-0432.ccr-19-1587.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2925_CR41","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.18632\/oncotarget.1738","volume":"5","author":"S Candido","year":"2014","unstructured":"Candido S, Maestro R, Polesel J, Catania A, Maira F, Signorelli SS, et al. Roles of Neutrophil Gelatinase-Associated Lipocalin (NGAL) in human cancer. Oncotarget. 2014;5(6):1576\u201394. https:\/\/doi.org\/10.18632\/oncotarget.1738.","journal-title":"Oncotarget"},{"issue":"3","key":"2925_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.32604\/or.2024.051672","volume":"33","author":"B Huang","year":"2025","unstructured":"Huang B, Jia Z, Fu C, Chen M, Su Z, Chen Y. Oncogenic and tumor-suppressive roles of Lipocalin 2 (LCN2) in tumor progression. Oncol Res. 2025;33(3):567\u201375. https:\/\/doi.org\/10.32604\/or.2024.051672.","journal-title":"Oncol Res"},{"issue":"6","key":"2925_CR43","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1158\/1535-7163.mct-20-0695","volume":"20","author":"ET Goka","year":"2021","unstructured":"Goka ET, Mesa Lopez DT, Lippman ME. Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and Survival. Molecular cancer therapeutics. 2021;20(6):1052-61. https:\/\/doi.org\/10.1158\/1535-7163.mct-20-0695","journal-title":"Molecular cancer therapeutics"},{"issue":"1","key":"2925_CR44","doi-asserted-by":"publisher","first-page":"18494","DOI":"10.1038\/s41598-024-69476-3","volume":"14","author":"J Yoshida","year":"2024","unstructured":"Cao H, Wang Y, Zhang D, Liu B, Zhou H, Wang S. Periprostatic Adipose Tissue: A new perspective for diagnosing and treating prostate cancer. Journal of Cancer. 2024;15(1):204-17. https:\/\/doi.org\/10.7150\/jca.89750.","journal-title":"Sci Rep"},{"issue":"3","key":"2925_CR45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1158\/1541-7786.mcr-18-0748","volume":"17","author":"V Laurent","year":"2019","unstructured":"Roumigui\u00e9\u00e9 M, Est\u00e8\u00e8ve D, Manceau C, Toulet A, Gilleron J, Belles C, et al. Periprostatic adipose tissue displays a chronic hypoxic state that limits its expandability. The American journal of pathology. 2022;192(6):926\u201342. https:\/\/doi.org\/10.1016\/j.ajpath.2022.03.008.","journal-title":"Mol Cancer Res"},{"issue":"9","key":"2925_CR46","doi-asserted-by":"publisher","first-page":"100396","DOI":"10.1016\/j.xcrm.2021.100396","volume":"2","author":"B Trinh","year":"2021","unstructured":"Ribeiro R, Monteiro C, Catal\u00e1\u00e1n V, Hu P, Cunha V, Rodr\u00ed\u00edguez A, et al. Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue. BMC medicine. 2012;10:108. https:\/\/doi.org\/10.1186\/1741-7015-10-108.","journal-title":"Cell Rep Med"},{"key":"2925_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.regpep.2014.10.001","volume":"194-195","author":"N Chen","year":"2014","unstructured":"Laurent V, Toulet A, Attan\u00e9\u00e9 C, Milhas D, Dauvillier S, Zaidi F, et al. Periprostatic adipose tissue favors prostate cancer cell invasion in an obesity-dependent manner: Role of Oxidative Stress. Molecular cancer research : MCR. 2019;17(3):821-35. https:\/\/doi.org\/10.1158\/1541-7786.mcr-18-0748.","journal-title":"Regul Pept"},{"issue":"5","key":"2925_CR48","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2337\/db10-1017","volume":"60","author":"L Qiao","year":"2011","unstructured":"Saha A, Ahn S, Blando J, Su F, Kolonin MG, DiGiovanni J. Proinflammatory CXCL12-CXCR4\/CXCR7 signaling axis drives myc-induced prostate cancer in obese mice. Cancer research. 2017;77(18):5158-68. https:\/\/doi.org\/10.1158\/0008-5472.can-17-0284.","journal-title":"Diabetes"},{"issue":"1","key":"2925_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.33549\/physiolres.931863","volume":"60","author":"Z Wedellov\u00e1","year":"2011","unstructured":"Liu G, Zhang J, Frey L, Gang X, Wu K, Liu Q, et al. Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue. Journal of hematology & oncology. 2017;10(1):14. https:\/\/doi.org\/10.1186\/s13045-016-0386-7.","journal-title":"Physiol Res"},{"issue":"12","key":"2925_CR50","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.1194\/jlr.m200227-jlr200","volume":"11","author":"H Li","year":"2019","unstructured":"La Civita E, Liotti A, Cennamo M, Crocetto F, Ferro M, Liguoro P, et al. Peri-Prostatic adipocyte-released TGF\u03b2 enhances prostate cancer cell motility by upregulation of connective tissue growth factor. Biomedicines. 2021;9(11). https:\/\/doi.org\/10.3390\/biomedicines9111692.","journal-title":"Am J Transl Res"},{"issue":"12","key":"2925_CR51","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1194\/jlr.m200227-jlr200","volume":"43","author":"AV Hertzel","year":"2002","unstructured":"Zhang Q, Sun LJ, Yang ZG, Zhang GM, Huo RC. Influence of adipocytokines in periprostatic adipose tissue on prostate cancer aggressiveness. Cytokine. 2016;85:148-56. https:\/\/doi.org\/10.1016\/j.cyto.2016.06.019.","journal-title":"J Lipid Res"},{"issue":"10","key":"2925_CR52","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1210\/en.2009-0119","volume":"150","author":"Y Hotta","year":"2009","unstructured":"Price RS, Cavazos DA, De Angel RE, Hursting SD, deGraffenried LA. Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells. Prostate cancer and prostatic diseases. 2012;15(2):135-43. https:\/\/doi.org\/10.1038\/pcan.2011.54.","journal-title":"Endocrinology"},{"key":"2925_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.coemr.2020.02.007","volume":"10","author":"D Est\u00e8ve","year":"2020","unstructured":"Rojas A, Liu G, Coleman I, Nelson PS, Zhang M, Dash R, et al. IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR. Oncogene. 2011;30(20):2345-55. https:\/\/doi.org\/10.1038\/onc.2010.605.11.","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"1","key":"2925_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5152\/tud.2016.08941","volume":"43","author":"N Mu\u015flu","year":"2017","unstructured":"Zhu F, Liu P, Li J, Zhang Y. Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression. Oncology reports. 2014;31(5):2049\u201354. https:\/\/doi.org\/10.3892\/or.2014.3060.","journal-title":"Turkish J Urol"},{"issue":"1","key":"2925_CR55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-nutr-071816-064559","volume":"37","author":"X Xiao","year":"2017","unstructured":"Cioni B, Nevedomskaya E, Melis MHM, van Burgsteden J, Stelloo S, Hodel E, et al. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration. Molecular oncology. 2018;12(8):1308\u201323. https:\/\/doi.org\/10.1002\/1878-0261.12327.","journal-title":"Annu Rev Nutr"},{"issue":"1","key":"2925_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1523\/jneurosci.2389-11.2012","volume":"32","author":"KW Poh","year":"2012","unstructured":"Xin H, Cao Y, Shao ML, Zhang W, Zhang CB, Wang JT, et al. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine\/paracrine fashion. International urology and nephrology. 2018;50(5):861\u20138. https:\/\/doi.org\/10.1007\/s11255-018-1818-9.","journal-title":"J Neurosci"},{"issue":"4","key":"2925_CR57","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2337\/db09-1541","volume":"59","author":"IK Law","year":"2010","unstructured":"Yan J, Smyth MJ, Teng MWL. Interleukin (IL)-12 and IL-23 and their conflicting roles in cancer. Cold Spring Harbor perspectives in biology. 2018;10(7). https:\/\/doi.org\/10.1101\/cshperspect.a028530.","journal-title":"Diabetes"},{"key":"2925_CR58","doi-asserted-by":"publisher","unstructured":"Tse BW, Russell PJ, Lochner M, F\u00f6\u00f6rster I, Power CA. IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms. PloS one. 2011;6(9):e24241. https:\/\/doi.org\/10.1371\/journal.pone.0024241.","DOI":"10.1371\/journal.pone.0024241"},{"key":"2925_CR59","doi-asserted-by":"publisher","first-page":"36138","DOI":"10.1038\/srep36138","volume":"6","author":"KC Chiang","year":"2016","unstructured":"Ribeiro R, Monteiro C, Silvestre R, Castela A, Coutinho H, Fraga A, et al. Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma. Experimental biology and medicine(Maywood, NJ). 2012;237(10):1155\u201362. https:\/\/doi.org\/10.1258\/ebm.2012.012131.","journal-title":"Sci Rep"},{"issue":"37","key":"2925_CR60","doi-asserted-by":"publisher","first-page":"14058","DOI":"10.1073\/pnas.0710846105","volume":"105","author":"A Iannetti","year":"2008","unstructured":"Yoshida J, Hayashi T, Munetsuna E, Khaledian B, Sueishi F, Mizuno M, et al. Adipsin-dependent adipocyte maturation induces cancer cell invasion in breast cancer. Scientific reports. 2024;14(1):18494. https:\/\/doi.org\/10.1038\/s41598-024-69476-3.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2925_CR61","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.yexmp.2011.06.002","volume":"91","author":"T Miyamoto","year":"2011","unstructured":"Trinh B, Peletier M, Simonsen C, Plomgaard P, Karstoft K, Klarlund Pedersen B, et al. Blocking endogenous IL-6 impairs mobilization of free fatty acids during rest and exercise in lean and obese men. Cell reports Medicine.2021;2(9):100396. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100396.","journal-title":"Exp Mol Pathol"},{"issue":"10","key":"2925_CR62","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1002\/ijc.21657","volume":"118","author":"HJ Lee","year":"2006","unstructured":"Chen N, Zhou L, Zhang Z, Xu J, Wan Z, Qin L. Resistin induces lipolysis and suppresses adiponectin secretion in cultured human visceral adipose tissue. Regulatory peptides. 2014;194-195:49\u201354. https:\/\/doi.org\/10.1016\/j.regpep.2014.10.001.","journal-title":"Int J Cancer"},{"key":"2925_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124365","author":"GS Santiago-S\u00e1nchez","year":"2020","unstructured":"Qiao L, Kinney B, Schaack J, Shao J. Adiponectin inhibits lipolysis in mouse adipocytes. Diabetes. 2011;60(5):1519\u201327. https:\/\/doi.org\/10.2337\/db10-1017.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2925_CR64","doi-asserted-by":"publisher","first-page":"L726","DOI":"10.1152\/ajplung.00080.2021","volume":"321","author":"S Guardado","year":"2021","unstructured":"Wedellov\u00e1\u00e1 Z, Dietrich J, Siklov\u00e1\u00e1-V\u00ed\u00edtkov\u00e1\u00e1 M, Kolo\u0161\u0161tov\u00e1\u00e1 K, Kov\u00e1\u00e1\u010d\u010dikov\u00e1\u00e1 M, Du\u0161\u0161kov\u00e1\u00e1 M, et al. Adiponectin inhibits spontaneous and catecholamine-induced lipolysis in human adipocytes of non-obese subjects through AMPK-dependent mechanisms. Physiological research. 2011;60(1):139\u201348. https:\/\/doi.org\/10.33549\/physiolres.931863.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"2925_CR65","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12964-019-0434-3","volume":"17","author":"Y Lu","year":"2019","unstructured":"Li H, Zhang Y, Wang F, Donelan W, Zona MC, Li S, et al. Effects of irisin on the differentiation and browning of human visceral white adipocytes. American journal of translational research. 2019;11(12):7410-21","journal-title":"Cell Commun Signal"},{"issue":"12","key":"2925_CR66","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/pros.22670","volume":"73","author":"MC Tung","year":"2013","unstructured":"Hertzel AV, Bennaars-Eiden A, Bernlohr DA. Increased lipolysis in transgenic animals overexpressing the epithelial fatty acid binding protein in adipose cells. Journal of lipid research. 2002;43(12):2105-11. https:\/\/doi.org\/10.1194\/jlr.m200227-jlr200.","journal-title":"Prostate"},{"key":"2925_CR67","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1471-2407-11-229","volume":"11","author":"NR Mahadevan","year":"2011","unstructured":"Hotta Y, Nakamura H, Konishi M, Murata Y, Takagi H, Matsumura S, et al. Fibroblast growth factor 21regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology.2009;150(10):4625\u201333. https:\/\/doi.org\/10.1210\/en.2009-0119.","journal-title":"BMC Cancer"},{"issue":"39","key":"2925_CR68","doi-asserted-by":"publisher","first-page":"64309","DOI":"10.18632\/oncotarget.11790","volume":"7","author":"G Ding","year":"2016","unstructured":"Est\u00e8\u00e8ve D, Roumigui\u00e9\u00e9 M, Manceau C, Milhas D, Muller C. Periprostatic adipose tissue: A heavy player in prostate cancer progression. Current Opinion in Endocrine and Metabolic Research. 2020;10:29-35. https:\/\/doi.org\/10.1016\/j.coemr.2020.02.007.","journal-title":"Oncotarget"},{"key":"2925_CR69","doi-asserted-by":"publisher","unstructured":"Mu\u015flu N, Ercan B, Akbay\u0131r S, Balc\u0131 \u015e, Ovla HD, Bozlu M. Neutrophil gelatinase-associated lipocalin asa screening test in prostate cancer. Turkish journal of urology. 2017;43(1):30-5. https:\/\/doi.org\/10.5152\/tud.2016.08941.","DOI":"10.5152\/tud.2016.08941"},{"issue":"6","key":"2925_CR70","doi-asserted-by":"publisher","first-page":"8836043","DOI":"10.1155\/2021\/8836043","volume":"2021","author":"MH Ulusoy","year":"2021","unstructured":"Poh KW, Yeo JF, Stohler CS, Ong WY. Comprehensive gene expression profiling in the prefrontal cortex links immune activation and neutrophil infiltration to antinociception. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2012;32(1):35-45. https:\/\/doi.org\/10.1523\/jneurosci.2389-11.2012.","journal-title":"Prostate Cancer"},{"issue":"1","key":"2925_CR71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.18632\/oncotarget.1738","volume":"149","author":"CV Dang","year":"2012","unstructured":"Xiao X, Yeoh BS, Vijay-Kumar M. Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation. Annual review of nutrition. 2017;37:103-30. 10.1523\/jneurosci.2389-11.2012 https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064559.","journal-title":"Cell"},{"issue":"1","key":"2925_CR72","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2012.03.003","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Law IK, Xu A, Lam KS, Berger T, Mak TW, Vanhoutte PM, et al. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes. 2010;59(4):872-82. https:\/\/doi.org\/10.2337\/db09-1541.","journal-title":"Cancer Cell"},{"issue":"18","key":"2925_CR73","doi-asserted-by":"publisher","first-page":"5158","DOI":"10.1158\/0008-5472.can-17-0284","volume":"77","author":"A Saha","year":"2017","unstructured":"Mosialou I, Shikhel S,Luo N, Petropoulou PI, Panitsas K, Bisikirska B, et al. Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes. The Journal of experimental medicine. 2020;217(10). https:\/\/doi.org\/10.1084\/jem.20191261.","journal-title":"Cancer Res"},{"key":"2925_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccr.2010.05.026","volume":"81","author":"PJ Russell","year":"2003","unstructured":"Chiang KC, Yeh TS, Wu RC, Pang JS, Cheng CT, Wang SY, et al. Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker. Scientific reports.2016;6:36138. https:\/\/doi.org\/10.1038\/srep36138.","journal-title":"Methods Mol Med"},{"issue":"2","key":"2925_CR75","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/01.ju.0000141580.30910.57","volume":"173","author":"RE Sobel","year":"2005","unstructured":"Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, Vascotto C, et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappa B-regulated gene, is a survival factor for thyroid neoplastic cells. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(37):14058-63. https:\/\/doi.org\/10.1073\/pnas.0710846105.","journal-title":"J Urol"},{"issue":"2","key":"2925_CR76","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.ju.0000149989.01263.dc","volume":"173","author":"RE Sobel","year":"2005","unstructured":"Miyamoto T, Asaka R, Suzuki A, Takatsu A, Kashima H, Shiozawa T. Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17)and its prognostic significance in endometrial carcinoma. Experimental and molecular pathology. 2011;91(2):563-8. https:\/\/doi.org\/10.1016\/j.yexmp.2011.06.002.","journal-title":"J Urol"},{"key":"2925_CR77","doi-asserted-by":"publisher","unstructured":"Lee HJ, Lee EK, Lee KJ, Hong SW, Yoon Y, Kim JS. Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. International journal of cancer. 2006;118(10):2490-7. https:\/\/doi.org\/10.1002\/ijc.21657","DOI":"10.1002\/ijc.21657"},{"issue":"6","key":"2925_CR78","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s11154-023-09838-w","volume":"24","author":"JM P\u00e9rez-G\u00f3mez","year":"2023","unstructured":"Santiago-S\u00e1\u00e1nchez GS, Pita-Grisanti V, Qui\u00f1\u00f1ones-D\u00ed\u00edaz B, Gumpper K, Cruz-Monserrate Z, Vivas-Mej\u00ed\u00eda PE. Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer. Int J Mol Sci. 2020;21(12). https:\/\/doi.org\/10.3390\/ijms21124365.","journal-title":"Rev Endocr Metab Disord"},{"key":"2925_CR79","doi-asserted-by":"publisher","first-page":"155527","DOI":"10.1016\/j.metabol.2023.155527","volume":"142","author":"HMA Javaid","year":"2023","unstructured":"Guardado S, Ojeda-Ju\u00e1\u00e1rez D, Kaul M, Nordgren TM. Comprehensive review of lipocalin 2-mediated effects in lung inflammation. American journal of physiology Lung cellular and molecular physiology. 2021;321(4):L726-l33. https:\/\/doi.org\/10.1152\/ajplung.00080.2021.","journal-title":"Metabolism"},{"issue":"1","key":"2925_CR80","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/15548627.2022.2062887","volume":"19","author":"U Gupta","year":"2023","unstructured":"Lu Y, Dong B, Xu F, Xu Y, Pan J, Song J, et al. CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition. Cell communication and signaling : CCS. 2019;17(1):118. https:\/\/doi.org\/10.1186\/s12964-019-0434-3.","journal-title":"Autophagy"},{"issue":"12","key":"2925_CR81","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1002\/oby.23581","volume":"30","author":"AD Herrera-Mart\u00ednez","year":"2022","unstructured":"Tung MC, Hsieh SC, Yang SF, Cheng CW, Tsai RT, Wang SC, et al. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells. The Prostate. 2013;73(12):1281-90. https:\/\/doi.org\/10.1002\/pros.22670.","journal-title":"Obesity"},{"issue":"5","key":"2925_CR82","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Mahadevan NR, Rodvold J, Almanza G, P\u00e9\u00e9rez AF, Wheeler MC, Zanetti M. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-\u03baB-dependent manner. BMC cancer. 2011;11:229. https:\/\/doi.org\/10.1186\/1471-2407-11-229.","journal-title":"Nat Immunol"},{"issue":"2","key":"2925_CR83","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179\u201388. https:\/\/doi.org\/10.1038\/nm.2279.","journal-title":"Nat Med"},{"key":"2925_CR84","doi-asserted-by":"publisher","unstructured":"Schr\u00f6\u00f6der SK, Pino\u00e9\u00e9-Schmidt M, Weiskirchen R. Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3. Cells. 2022;11(2). https:\/\/doi.org\/10.3390\/cells11020260","DOI":"10.3390\/cells11020260"},{"issue":"12","key":"2925_CR85","doi-asserted-by":"publisher","first-page":"100895","DOI":"10.1016\/j.jhepr.2023.100895","volume":"5","author":"H Liu","year":"2023","unstructured":"Ulusoy MH, Cirak Y, Adali Y. Predictive and Prognostic Role of Lipocalin-2 Expression in Prostate Cancer and Its Association with Gleason Score. Prostate cancer. 2021;2021:8836043. https:\/\/doi.org\/10.1155\/2021\/8836043.","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"12","key":"2925_CR86","doi-asserted-by":"publisher","first-page":"9910","DOI":"10.1002\/jcp.29806","volume":"235","author":"XQ Luo","year":"2020","unstructured":"Dang Chi V. MYC on the Path to Cancer. Cell. 2012;149(1):22-35. https:\/\/doi.org\/10.1016\/j.cell.2012.03.003.","journal-title":"J Cell Physiol"},{"issue":"7","key":"2925_CR87","doi-asserted-by":"publisher","first-page":"5305306","DOI":"10.1155\/2020\/5305306","volume":"2020","author":"A Samiea","year":"2020","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative Genomic Profiling of Human Prostate Cancer. Cancer Cell.2010;18(1):11-22. https:\/\/doi.org\/10.1016\/j.ccr.2010.05.026.","journal-title":"Prostate Cancer"},{"issue":"8","key":"2925_CR88","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/1878-0261.12327","volume":"12","author":"B Cioni","year":"2018","unstructured":"Russell PJ, Kingsley EA. Human prostate cancer cell lines. Methods in molecular medicine.2003;81:21-39. 10.1016\/j.ccr.2010.05.026 https:\/\/doi.org\/10.1385\/1-59259-372-0:21.","journal-title":"Mol Oncol"},{"issue":"1","key":"2925_CR89","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12013-014-9941-4","volume":"70","author":"Q Gao","year":"2014","unstructured":"Sobel RE, Sadar MD. Cell lines used in prostate cancer research: a compendium of old and new lines--part 1. The Journal of urology. 2005;173(2):342-59. https:\/\/doi.org\/10.1097\/01.ju.0000141580.30910.57.","journal-title":"Cell Biochem Biophys"},{"issue":"19","key":"2925_CR90","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1128\/mcb.00413-12","volume":"32","author":"M Jung","year":"2012","unstructured":"Sobel RE, Sadar MD. Cell lines used in prostate cancer research: a compendium of old and new lines--part 2. The Journal of urology. 2005;173(2):360-72. https:\/\/doi.org\/10.1097\/01.ju.0000149989.01263.dc.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2925_CR91","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"34","author":"CE Thomas","year":"2023","unstructured":"Kim SL, Shin MW, Kim SW. Lipocalin 2 activates the NLRP3 inflammasome via LPS\u2011induced NF\u2011\u03baB signaling and plays a role as a pro\u2011inflammatory regulator in murine macrophages. Molecular medicine reports. 2022;26(6). https:\/\/doi.org\/10.3892\/mmr.2022.12875.","journal-title":"Cancer Causes Control : CCC"},{"issue":"15","key":"2925_CR92","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s10552-022-01639-x","volume":"70","author":"E Comp\u00e9rat","year":"2010","unstructured":"P\u00e9\u00e9rez-G\u00f3\u00f3mez JM, Montero-Hidalgo AJ, Fuentes-Fayos AC, Sarmento-Cabral A, Guzm\u00e1\u00e1n-Ruiz R, Malag\u00f3\u00f3n MM, et al. Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity. Reviews in endocrine & metabolic disorders.2023;24(6):1165-87. https:\/\/doi.org\/10.1007\/s11154-023-09838-w.","journal-title":"Prostate"},{"issue":"Pt A","key":"2925_CR93","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mce.2017.03.012","volume":"462","author":"Z Culig","year":"2018","unstructured":"Javaid HMA, Ko E, Joo EJ, Kwon SH, Park JH, Shin S, et al. TNF\u03b1-induced NLRP3 inflammasome mediates adipocyte dysfunction and activates macrophages through adipocyte-derived lipocalin 2. Metabolism. 2023;142:155527. https:\/\/doi.org\/10.1016\/j.metabol.2023.155527.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2925_CR94","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/15548627.2022.2062887","volume":"4","author":"ML De Santis","year":"2004","unstructured":"Gupta U, Ghosh S, Wallace CT, Shang P, Xin Y, Nair AP, et al. Increased LCN2 (lipocalin 2) in the RPE decreases autophagy and activates inflammasome-ferroptosis processes in a mouse model of dry AMD. Autophagy. 2023;19(1):92-111. https:\/\/doi.org\/10.1080\/15548627.2022.2062887","journal-title":"J Exp Ther Oncol"},{"issue":"1","key":"2925_CR95","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3233\/tub-211507","volume":"43","author":"Y Takeba","year":"2021","unstructured":"Herrera-Mart\u00ed\u00ednez AD, Herrero-Aguayo V, P\u00e9\u00e9rez-G\u00f3\u00f3mez JM, Gahete MD, Luque RM. Inflammasomes: Cause or consequence of obesity-associated comorbidities in humans. Obesity (Silver Spring, Md). 2022;30(12):2351-62. https:\/\/doi.org\/10.1002\/oby.23581.","journal-title":"Tumour Biol"},{"issue":"1","key":"2925_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13045-016-0386-7","volume":"10","author":"G Liu","year":"2017","unstructured":"Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nature immunology.2021;22(5):550-9. https:\/\/doi.org\/10.1038\/s41590-021-00886-5.","journal-title":"J Hematol Oncol"},{"issue":"16","key":"2925_CR97","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/pros.21029","volume":"69","author":"CH Tang","year":"2009","unstructured":"Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. TheNLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature medicine. 2011;17(2):179-88. https:\/\/doi.org\/10.1038\/nm.2279.","journal-title":"Prostate"},{"issue":"11","key":"2925_CR98","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1002\/ijc.28903","volume":"135","author":"H Uehara","year":"2014","unstructured":"Wani K, AlHarthi H, Alghamdi A, Sabico S, Al-Daghri NM. Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders. International journal of environmental research and public health. 2021;18(2). https:\/\/doi.org\/10.3390\/ijerph18020511.","journal-title":"Int J Cancer"},{"issue":"19","key":"2925_CR99","doi-asserted-by":"publisher","first-page":"9417","DOI":"10.1158\/0008-5472.can-07-1286","volume":"67","author":"RD Loberg","year":"2007","unstructured":"Liu H, Yeung WHO, Pang L, Liu J, Liu XB, Pan Ng KT, et al. Arachidonic acid activatesNLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts. JHEP reports : innovation in hepatology. 2023;5(12):100895. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100895.","journal-title":"Cancer Res"},{"issue":"1","key":"2925_CR100","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Luo XQ, Duan JX, Yang HH, Zhang CY, Sun CC, Guan XX, et al. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages. Journal of cellular physiology.2020;235(12):9910-21. https:\/\/doi.org\/10.1002\/jcp.29806.","journal-title":"Cell"},{"issue":"6","key":"2925_CR101","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/bju.12452","volume":"113","author":"DP Nguyen","year":"2014","unstructured":"Gao Q, Zheng J. Adiponectin-induced antitumor activity on prostatic cancers through inhibiting proliferation. Cell biochemistry and biophysics. 2014;70(1):461-5. https:\/\/doi.org\/10.1007\/s12013-014-9941-4.","journal-title":"BJU Int"},{"issue":"1","key":"2925_CR102","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ni.3306","volume":"17","author":"CK Glass","year":"2016","unstructured":"Jung M, Weigert A, Tausendsch\u00f6\u00f6n M, Mora J, \u00d6\u00d6ren B, Sola A, et al. Interleukin-10-induced neutrophil gelatinase-associated lipocalin production in macrophages with consequences for tumor growth. Molecular and cellular biology. 2012;32(19):3938-48. https:\/\/doi.org\/10.1128\/mcb.00413-12.","journal-title":"Nat Immunol"},{"issue":"4","key":"2925_CR103","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Samiea A, Yoon JSJ, OngCJ, Zoubeidi A, Chamberlain TC, Mui AL. Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells. Prostate cancer. 2020;2020:5305306. https:\/\/doi.org\/10.1155\/2020\/5305306.","journal-title":"Mol Cell"},{"issue":"3","key":"2925_CR104","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","volume":"33","author":"B Ruffell","year":"2012","unstructured":"Thomas CE, Bauer DC, Yuan JM, Cauley JA. Circulating IL-10 is associated with reduced risk of prostate cancer in a prospective cohort of elderly men: the MrOS Study. Cancer causes & control : CCC. 2023;34(1):59-68.10.1186\/gb-2002-3-7-research0034 https:\/\/doi.org\/10.1007\/s10552-022-01639-x.","journal-title":"Trends Immunol"},{"issue":"6","key":"2925_CR105","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1158\/1535-7163.mct-20-0695","volume":"20","author":"ET Goka","year":"2021","unstructured":"Comp\u00e9\u00e9rat E, Roupr\u00ea\u00eat M, Drouin SJ, Camparo P, Bitker MO, Houlgatte A, et al. Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy. The Prostate.2010;70(15):1622-7. 10.1007\/s10552-022-01639-x https:\/\/doi.org\/10.1002\/pros.21197.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"2925_CR106","doi-asserted-by":"publisher","first-page":"204","DOI":"10.7150\/jca.89750","volume":"15","author":"H Cao","year":"2024","unstructured":"Culig Z, Puhr M. Interleukin-6 and prostate cancer: Current developments and unsolved questions. Molecular and cellular endocrinology. 2018;462(Pt A):25-30. https:\/\/doi.org\/10.1016\/j.mce.2017.03.012.","journal-title":"J Cancer"},{"issue":"6","key":"2925_CR107","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.ajpath.2022.03.008","volume":"192","author":"M Roumigui\u00e9","year":"2022","unstructured":"DeSantis ML, Hammamieh R, Das R, Jett M. Adipocyte-fatty acid binding protein induces apoptosis in DU145 prostate cancer cells. Journal of experimental therapeutics & oncology. 2004;4(2):91-100..","journal-title":"Am J Pathol"},{"key":"2925_CR108","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1741-7015-10-108","volume":"10","author":"R Ribeiro","year":"2012","unstructured":"Takeba Y, Ohta Y, Ootaki M, Kobayashi T, Kida K, Watanabe M, et al. Identification of interleukin-16 production on tumor aggravation in hepatocellular carcinoma by a proteomics approach. Tumour biology : the journal of the International Society for Onco developmental Biology and Medicine. 2021;43(1):309-25. https:\/\/doi.org\/10.3233\/tub-211507.","journal-title":"BMC Med"},{"issue":"11","key":"2925_CR109","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/biomedicines9111692","volume":"9","author":"E La Civita","year":"2021","unstructured":"Tang CH, Lu ME. Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappa B pathways. The Prostate.2009;69(16):1781-9. https:\/\/doi.org\/10.1002\/pros.21029.","journal-title":"Biomedicines."},{"issue":"2","key":"2925_CR110","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/pcan.2011.54","volume":"15","author":"RS Price","year":"2012","unstructured":"Uehara H, Takahashi T, Oha M, Ogawa H, Izumi K. Exogenous fatty acid binding protein 4promotes human prostate cancer cell progression. International journal of cancer. 2014;135(11):2558-68. https:\/\/doi.org\/10.1002\/ijc.28903.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"20","key":"2925_CR111","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1038\/onc.2010.605","volume":"30","author":"A Rojas","year":"2011","unstructured":"Loberg RD, Ying C, Craig M, Day LL, Sargent E, Neeley C, et al. Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer research. 2007;67(19):9417-24. https:\/\/doi.org\/10.1158\/0008-5472.can-07-1286.","journal-title":"Oncogene"},{"key":"2925_CR112","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cyto.2016.06.019","volume":"85","author":"Q Zhang","year":"2016","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell.2010;141(1):39-51. https:\/\/doi.org\/10.1016\/j.cell.2010.03.014.","journal-title":"Cytokine"},{"issue":"5","key":"2925_CR113","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.3892\/or.2014.3060","volume":"31","author":"F Zhu","year":"2014","unstructured":"Nguyen DP, Li J, Tewari AK. Inflammation and prostate cancer: the role of interleukin 6 (IL-6).BJU international. 2014;113(6):986-92. https:\/\/doi.org\/10.1111\/bju.12452.","journal-title":"Oncol Rep"},{"issue":"5","key":"2925_CR114","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11255-018-1818-9","volume":"50","author":"H Xin","year":"2018","unstructured":"Glass CK, Natoli G. Molecular control of activation and priming in macrophages. Nature immunology. 2016;17(1):26-33. https:\/\/doi.org\/10.1038\/ni.3306.","journal-title":"Int Urol Nephrol"},{"key":"2925_CR115","doi-asserted-by":"publisher","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Molecular cell.2010;38(4):576-89. https:\/\/doi.org\/10.1016\/j.molcel.2010.05.004","DOI":"10.1016\/j.molcel.2010.05.004"},{"issue":"9","key":"2925_CR116","doi-asserted-by":"publisher","first-page":"e24241","DOI":"10.1371\/journal.pone.0024241","volume":"6","author":"BW Tse","year":"2011","unstructured":"Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends in immunology. 2012;33(3):119-26. https:\/\/doi.org\/10.1016\/j.it.2011.12.001.","journal-title":"PLoS ONE"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02925-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02925-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02925-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:59:12Z","timestamp":1781769552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02925-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2925"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02925-w","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study involved both human tissue samples and animal models. The clinical research was conducted in accordance with the principles of the Declaration of Helsinki and was formally approved by the Ethics Committee of the Reina Sofia University Hospital (ref. 0170-N-23). All human samples were histologically confirmed by expert pathologists and were collected, processed, and handled by the regional node of the Andalusian Biobank in Cordoba following standardized protocols. All patients provided written informed consent prior to sample collection. Regarding the preclinical studies, all experimental procedures were approved by the Institutional Animal Care and Use Committee of the Institute for Agricultural and Fisheries Research and Training (IFAPA, Junta de Andaluc\u00eda), Spain (Protocol No. 19\/04\/2023\/13). In accordance with the approved protocol, the maximal tumor burden permitted was defined as a maximum diameter of 1.5\u00a0cm or a tumor weight exceeding 10% of the animal\u2019s total body weight, and we confirm that these limits were not exceeded in any experimental subject. Furthermore, animals were monitored daily for humane endpoints, including body condition score, rapid weight loss (15\u201320%), impaired mobility, respiratory distress, dehydration, or signs of tumor ulceration and necrosis, with no subjects reaching these predefined endpoints before the scheduled completion of the experiment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person's data in any form (including individual details, images, or videos).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"360"}}